Literature DB >> 16484886

Beneficial response to rituximab in refractory Felty Syndrome.

Nicole Weinreb, Arthur Rabinowitz, Paul F Dellaripa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16484886     DOI： 10.1097/01.rhu.0000200326.17729.76

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  3 in total

Review 1.  The spectrum of large granular lymphocyte leukemia and Felty's syndrome.

Authors:  Xin Liu; Thomas P Loughran
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

2.  Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome.

Authors:  Klaus Stahl; Michelle Duong; Anke Schwarz; A D Wagner; Hermann Haller; Mario Schiffer; Roland Jacobs
Journal:  Case Rep Nephrol       Date:  2017-01-24

3.  Targeted Therapy with Rituximab in Felty's Syndrome: A Case Report.

Authors:  Line Heylen; Daan Dierickx; Peter Vandenberghe; René Westhovens
Journal:  Open Rheumatol J       Date:  2012-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.